NovoCare Pharmacy Review
Semaglutide GLP-1 weight-loss telehealth · Independently scored 7.9/10
Best for: an oral route if you will not self-inject
What NovoCare Pharmacy does best is charge less than most of the register.
Covered by the monthly price
Medication
Not stated
Clinician visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
NovoCare Pharmacy is Novo Nordisk's own first-party direct-to-consumer pharmacy for branded Wegovy (semaglutide), a manufacturer-owned channel. Wegovy 0.25 mg and 0.5 mg starter doses run $199/month through 6/30/2026; full-dose Wegovy is $349/month at standard self-pay, and Wegovy HD is $399/month. It ships nationwide. Telehealth platforms that route Wegovy through NovoCare are a separate thing from the manufacturer pharmacy itself.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Vetted alternatives to NovoCare Pharmacy
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
NovoCare Pharmacy at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Wegovy
- Starting price
- $25/mo (with commercial insurance, as little as $25/mo; subject to max savings of $100/month)
- Pricing model
- Scales with dose — higher doses cost more
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How NovoCare Pharmacy scores
Six columns, each one computed from something NovoCare Pharmacy has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where it publishes nothing, that absence is what gets scored. Every seller in the register goes through the same six columns.
Value25%
10.0/10$349/month is 73% below the register median of $1299 for brand semaglutide.
Effectiveness25%
9.0/10Dispenses semaglutide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
5.0/10Where this seller first shows a price is not recorded yet, so the signup is unscored and sits at the midpoint.
Trust & Safety15%
6.0/10does not name a dispensing pharmacy; withholds price until after the intake; publishes its state list. Our verification confidence is high.
Accessibility10%
10.0/10Publishes coverage in 50 of 50 states.
Support10%
5.0/10States too little about what the monthly cost covers to score the bundle. Held at the midpoint rather than assumed.
A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →
What we checked on NovoCare Pharmacy
Last checked August 2026- Re-read the price on file across 4 dose or plan tiers
- Checked state coverage: all 50
- Searched our FDA enforcement register for this operator
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below. Editorial confidence in this data: high.
GLP-1 medications NovoCare Pharmacy offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
$149/mo for 1.5 mg and 4 mg new self-pay; 4 mg offer ends 8/31/2026, then $199/mo for 4 mg
$199/mo intro = first 2 monthly fills (0.25/0.5 mg) for patients new to the offer/pharmacy, through 6/30/2026; then $349/mo standard
with commercial insurance, as little as $25/mo; subject to max savings of $100/month
Check the price yourself before you pay
Every figure here was read off NovoCare Pharmacy's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide at $149 a month, within the normal band around this register's $199 median for the same drug and form
- Coverage is published for all 50 states
- No FDA warning letter matched this operator when we searched our enforcement register
- Both oral and injectable options are on record, so the format is a choice rather than a condition
Against it
- No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
What NovoCare Pharmacy charges
NovoCare Pharmacy lists $149/month. That sits at the affordable end of what we track.
- semaglutide — $149/month
- Brand-name semaglutide — $199 first month, then $349/month
- Brand-name semaglutide — $399/month
- Brand-name semaglutide — $25/month
Across the GLP-1 providers in our register the median standing price is about $169/month, so NovoCare Pharmacy is genuinely under the middle rather than merely advertising that it is.
Found, at about $149/month, is the closest thing we track to a like-for-like alternative.
What NovoCare Pharmacy dispenses
NovoCare Pharmacy prescribes semaglutide (approved as Wegovy and Ozempic). Between them these are one of the most heavily studied molecules in this class. These are FDA-approved brand-name products rather than compounded preparations, which is the more expensive route and the one where what is in the vial has been reviewed.
What we could verify
On the record: it treats patients in all 50 states. We searched the federal warning-letter record for this operator and came back with nothing. How we weigh oversight, disclosure and price evidence is set out in our scoring methodology.
Who should look elsewhere
- You need to bill insurance. Like most of this market, this is cash-pay.
It fits if
- the lowest standing monthly cost is what you are solving for
- you need access regardless of where you live
Our read
NovoCare Pharmacy competes on price and does it without an obvious sacrifice elsewhere: $149/month, no warning letter on file, and access that is not unusually restricted.
The Bottom Line
What NovoCare Pharmacy does best is charge less than most of the register.
Before you pay NovoCare Pharmacy
Starting at $149/month. Check today's price, then book the free consultation.
Where NovoCare Pharmacy is the wrong choice
No seller in this register suits every reader, and saying otherwise would be the easiest way to sell one. On these four counts another entry does better.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this NovoCare Pharmacy review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
See NovoCare Pharmacy's current pricing
Plans start at $149/month. The free consultation is where you learn whether you qualify, and what it costs today.